Through its publications, INSS provides rigorous, forward‑looking research and analysis on critical national security issues that support the joint warfighter and inform Department of War decision‑makers.
Nov. 3, 2015
In Good Health? The Biological Weapons Convention and the “Medicalization” of Security
Since the 1990s, the group of stakeholders working to combat biological weapons (BW) proliferation has broadened to include new actors who have not traditionally focused on security issues, including organizations from the public health sector, researchers in the life sciences, and the biosafety community.
July 1, 2015
The History of Biological Weapons Use: What We Know and What We Don’t
This article critically reviews the literature on the history of biological warfare, bioterrorism, and biocrimes.
Oct. 1, 2009
President Nixon’s Decision to Renounce the U.S. Offensive Biological Weapons Program
The nuclear arms race between the United States and the Soviet Union was a prominent feature of the Cold War. A lesser known but equally dangerous element of the superpower competition involved biological weapons (BW), living microorganisms that cause fatal or incapacitating diseases in humans, animals, or plants. By the late 1960s, the United States and the Soviet Union had both acquired advanced BW capabilities. The U.S. biological weapons complex, operated by the U.S. Army Chemical Corps, consisted of a research and development laboratory at Fort Detrick in Maryland, an open-air testing site at Dugway Proving Ground in Utah, and a production facility at Pine Bluff Arsenal in Arkansas that manufactured biological warfare agents and loaded them into bomblets, bombs, and spray tanks.
June 1, 2009
Are We Prepared? Four WMD Crises That Could Transform U.S. Security
This report, written by the staff of the National Defense University Center for the Study of Weapons of Mass Destruction in the fall of 2008 and the early winter of 2009, was conceived initially as a transition paper for the new administration following the 2008 American Presidential election.
April 1, 2003
Toward a National Biodefense Strategy
The United States is re-learning an important lesson in the first decade of the 21st century: adversaries may attack the United States, its interests, or those of friends and allies with biological weapons (BW).
Nov. 1, 2002
Anthrax in America: A Chronology and Analysis of the Fall 2001 Anthrax Attacks
This paper describes the 2001 anthrax attacks on the United States and provides a one-year snapshot of the attacks and subsequent response.
Dec. 1, 2001
Adversary Use of NBC Weapons: A Neglected Challenge
This article describes how thinking regarding how an adversary might use nuclear, radiological, biological, or chemical weapons against the United States changed in the last decade of the 20th century.
Feb. 1, 2001
Bioterrorism and Biocrimes: the Illicit Use of Biological Arms in the 20th century
This working paper is an updated study of research that began in 1998; it provides a descriptive analysis of the illicit use of biological agents by criminals and terrorists in the 20th century and draws on a series of specific case studies.
Dec. 1, 1999
DOD and Consequence Management: Mitigating the Effects of Chemical and Biological Attack
This article aims to analyze the potential threat of chemical and biological weapons to the U.S. It also offers recommendations on how to approach these situations and respond appropriately.